New York’s Vireo Health has received approval from the state Department of Health to launch a medical cannabis home delivery program – the first company approved for that purpose after the agency amended the medical cannabis program rules last month.
Vireo Health will offer deliveries in an eight-county zone, which includes Long Island, Westchester and all five New York City boroughs. In a press release, the company indicated that deliveries will be made in vehicles employing “cutting-edge safety features” including GPS tracking and a minimum of two employees will be present on all deliveries.
“Home delivery will not only help us to improve upon current services, but also expand our reach to those patients who are unable to travel,” Dr. Stephen Dahmer, Vireo’s chief medical officer, said. “Our team is excited to provide this service to all of our existing patients, and to have the opportunity to meet new patients in other parts of the state.”
Vireo CEO Ari Hoffnung said that the move will allow the company to “meet and exceed patient expectations.” The company expects to unveil details of the plan, such as pricing, “over the coming weeks,” and are planning to launch the service in 90 days.
Ganjapreneur: Offering daily insights since 2014, the leading digital business journal for cannabis industry professionals. Subscribe to the newsletter to join our community of over 40,000 ganjapreneurs.
